Back to Ventana Biotech homepage
Home Business Product Licensing Alliances Management Team Investor Relations Contact Us Press Releases

Press Releases


View Archive (2 Items) Page 1 of 2

1.
Ventana - Sale of IP Update
Ventana Biotech Inc. (”Ventana”) (VNTA.PK) today announced that the closing for the sale of its IP is still ongoing. The terms of the deal have already been agreed and it presents a value as per the date of the original offer and therefore a value significantly higher than what the curre...
Read More: http://www.ventanabiotech.com/news/201/ventana-sale-of-ip-update

2.
Ventana Enters Final Stage of Negotiations
Ventana Biotech Inc. (”Ventana”) (VNTA.PK), a biotechnology company developing an appetite-suppressing and stress reducing chewing gum, today announced that it has entered into the final stages of negotiations for the sale of its current IP and product pipeline. As mentioned in a pre...
Read More: http://www.ventanabiotech.com/news/200/ventana-enters-final-stage-of-negotiations

3.
Ventana pre-liminary offer for its IP
Ventana Biotech Inc. (”Ventana”) (VNTA.PK), a biotechnology company developing an appetite-suppressing and stress reducing chewing gum, today announced it has been contacted by a US company for the acquisition of its intellectual property. Ventana was approached by a US based compan...
Read More: http://www.ventanabiotech.com/news/199/ventana-pre-liminary-offer-for-its-ip

4.
Ventana issues clarifying press release
Ventana Biotech Inc. (”Ventana”) (VNTA.PK), a biotechnology company developing an appetite-suppressing and stress reducing chewing gum, clarified today information disseminated in previous press releases regarding becoming a fully reporting OTCBB issuer. The Company has retained leg...
Read More: http://www.ventanabiotech.com/news/198/ventana-issues-clarifying-press-release

5.
Ventana enters into a multi billion dollar market
Ventana Biotech Inc. ("Ventana") (VNTA.PK), a biotechnology company developing an appetite-suppressing chewing gum, today revealed its progress in the groundbreaking research in tackling yet another of the modern lifestyle-induced illnesses: Stress! Ventana is proud to announce that its...
Read More: http://www.ventanabiotech.com/news/153/ventana-enters-into-a-multi-billion-dollar-market

6.
PE Consortium and Ventana signs agreement for collaborative venture
Ventana Biotech Inc ("Ventana") (VNTA.PK), a biotechnology company that is developing a ground breaking appetite-suppressing chewing gum today announced it has signed is in collaboration negotiations with PE Consortium Ltd, a company that focuses on the research and development and outsou...
Read More: http://www.ventanabiotech.com/news/152/pe-consortium-and-ventana-signs-agreement-for-collaborative-venture

7.
Combatting stress with stress-suppressing chewing gum
Ventana Biotech Inc. (”Ventana”) (VNTA.PK), a biotechnology company developing an appetite-suppressing chewing gum, today revealed its latest groundbreaking research in tackling yet another of the modern lifestyle-induced illnesses: Stress! Ventana Biotech Inc. is proud to reveal that...
Read More: http://www.ventanabiotech.com/news/143/combatting-stress-with-stress-suppressing-chewing-gum

8.
Combatting obesity with appetite-suppressing chewing gum
Ventana Biotech Inc ("Ventana") (VNTA.PK), a biotechnology company that is developing a appetite-suppressing chewing gum, today released information about its groundbreaking appetite-regulating biotechnology. With Ventana’s proprietary Anti-Obesity Chewing Gum, users can safely co...
Read More: http://www.ventanabiotech.com/news/142/combatting-obesity-with-appetite-suppressing-chewing-gum

9.
Ventana appoints Vijay Guptha to scientific advisory board
Ventana Biotech Inc ("Ventana") (VNTA.PK), a biotechnology company that develops anti-obesity solutions, today announced its appointment of Vijay Guptha, PhD, to its Advisory Board. Mr. Guptha will contribute his expertise and pharmaceutical experience to Ventana’s business of sou...
Read More: http://www.ventanabiotech.com/news/141/ventana-appoints-vijay-guptha-to-scientific-advisory-board

10.
Ventana's promising new anti-obesity patent
Ventana Biotech Inc ("Ventana") (VNTA.PK), a biotechnology company that is developing a appetite-suppressing chewing gum, today released detailed information about its innovative Anti-Obesity Chewing Gum. The goal of Ventana’s Anti-Obesity Chewing Gum is to combat the growing glob...
Read More: http://www.ventanabiotech.com/news/140/ventanas-promising-new-anti-obesity-patent

1 2 Next >>
© Copyright 2010 Ventana Biotech  |   Privacy Policy  |  Disclaimer